Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeller Regulatory News (KLR)

Share Price Information for Keller (KLR)

Share Price is delayed by 15 minutes
Get Live Data
2,390.00    -68.00 (-2.77%)
Bid:
2,390.00
Ask:
2,484.00
Spread: 94.00 (3.933%)
Market Cap: £1.68b
KLR Live PriceLast checked at - London Stock Exchange

Intraday Keller Share Chart

Holding(s) in Company

24 May 2010 10:12

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are Keller Group PLCattached:ii 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the BlackRock, Inc. notification obligation:iii 4. Full name of shareholder(s) (if different from 3.):iv 5. Date of the transaction and date on which the threshold is crossed or 19th May 2010 reached: v 6. Date on which issuer notified: 21st May 2010 7. Threshold(s) that is/are crossed or Holding has gone below 13%reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix

Class/type Situation previous Resulting situation after the triggering transaction of

to the triggering shares transaction Number Number Number Number of voting % of voting rights x if possible of of of shares rights using Shares Voting the ISIN Rights Direct Direct xi Indirect Direct Indirect CODE xii GB0004866223 6,597,788 6,597,788 N/A N/A 6,540,266 N/A 10.171% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting % of voting financial date xiii Conversion Period rights that may be rights instrument xiv acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of Exercise price Expiration Exercise/ Number of voting rights % of voting rightsfinancial date xvii Conversion instrument refers to xix, xx instrument period xviii Nominal Delta CFD 1,817,401 2.826% 2.826% Total (A+B+C) Number of voting rights Percentage of voting rights 8,357,667 12.997%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

BlackRock Investment Management (UK) Limited - 8,357,667 (12.997%) Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: BlackRock Threshold Reporting Team 13. Additional information: 14. Contact name: Stuart Watchorn 15. Contact telephone number: 020 7743 5741; stuart.watchorn@blackrock.com

Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii A: Identity of the persons or legal entity subject to the notification obligation Full name (including legal form of legal entities) BlackRock, Inc. Contact address 33 King William Street, (registered office for legal entities) London, EC4R 9AS Phone number & email 020 7743 5741; stuart.watchorn@blackrock.com Other useful information (at least legal representative for legal persons) Stuart Watchorn B: Identity of the notifier, if applicable Full name Contact address Phone number & email Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

vendor
Date   Source Headline
9th Jun 20267:00 amRNSMulti-year US highway contract variation award
9th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20268:30 amPRNTotal Voting Rights
27th May 20267:00 amRNSTransaction in Own Shares
22nd May 20264:16 pmPRNHolding(s) in Company
20th May 202611:06 amPRNResult of AGM
20th May 20267:00 amRNSAGM Trading Update
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20269:09 amPRNHolding(s) in Company
12th May 20267:00 amRNSTransaction in Own Shares
7th May 202610:32 amPRNHolding(s) in Company
6th May 202612:00 pmPRNHolding(s) in Company
6th May 202611:13 amPRNDirector Declaration
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20264:30 pmPRNHolding(s) in Company
1st May 20268:30 amPRNTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20264:51 pmPRNDirector/PDMR Shareholding
14th Apr 20262:53 pmPRNNotice of 2026 Annual General Meeting
14th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSMichael Speakman
8th Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amPRNLaunch of £100 million share buyback tranche
24th Mar 20264:40 pmPRNDirector/PDMR Shareholding
24th Mar 202610:15 amPRNAnnual Financial Report
20th Mar 202610:01 amPRNStatement re Company Event
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20269:08 amPRNDirector/PDMR Shareholding
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 202612:30 pmPRNDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20264:34 pmPRNDirector/PDMR Shareholding
4th Mar 20267:15 amPRNDirector Declaration
3rd Mar 20267:00 amRNSPreliminary Results for the year ended 31 Dec 2025
2nd Mar 20268:30 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.